GU
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Prostate Cancer Take-Home Messages
FEATURING
Eleni Efstathiou
- 534 views
- July 29, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications for the Practicing Oncologist"
FEATURING
Kriti Mittal
- 316 views
- July 16, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Bladder and RCC Highlights"
FEATURING
Karine Tawagi,
Natalie Reizine
- 224 views
- July 16, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Prostate Cancer Highlights"
FEATURING
Natalie Reizine,
Karine Tawagi
- 508 views
- July 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 508 views
- July 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
Bladder Cancer Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 1,287 views
- June 10, 2024
- 8
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiraterone vs. Abiraterone Alone Post-Docetaxel for mCRPC"
FEATURING
Christos Kyriakopoulos
- 339 views
- June 12, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic Model for Predicting OS in Men With mCRPC Treated With Potent AR Inhibition (Alliance)"
FEATURING
Susan Halabi
- 153 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favorable Risk mRCC - Real-World Evidence From the IMDC"
FEATURING
Martin Zarba
- 235 views
- June 7, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MAST Study - Metformin in Reducing Progression Among Men on Expectant Management for Low-Risk Prostate Cancer"
FEATURING
Neil Fleshner
- 166 views
- June 11, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "TRANSFORMER Trial - Blood-Based Markers of Differential Efficacy of Bipolar Androgen Therapy and Enzalutamide in mCRPC"
FEATURING
Emmanuel Antonarakis
- 155 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfortumab Vedotin in Patients With Locally Advanced or Metastatic Urothelial Cancer"
FEATURING
Daniel Petrylak
- 155 views
- June 6, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - Key Updates From the MANCAN2, EMBARK, PRESTO, and PSMAfore Trials"
FEATURING
Channing Paller
- 159 views
- June 26, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Advances in RCC and Urothelial Carcinoma - Key Updates From the CheckMate 9ER, JAVELIN Renal 101, and CheckMate 901 Trials"
FEATURING
Camillo Porta
- 80 views
- June 26, 2024
ecancer
ASCO® 2024 Summary: "Expert Panel Discussion on the Real World Evidence on PSA Testing in Prostate Cancer"
- 177 views
- June 24, 2024
ecancer
ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices in HRRm Testing in Patients With Metastatic Prostate Cancer"
- 166 views
- June 24, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KEYNOTE-426 Trial - Biomarker Analysis of Pembro + Axitinib vs. Sunitinib for aRCC"
FEATURING
Brian Rini
- 90 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Organ Preserving and Reconstructive Surgery in Penile Cancer"
FEATURING
Arthur Burnett
- 144 views
- June 19, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CYCLONE 2 Study - Abemaciclib + Abiraterone in mCRPC"
FEATURING
Tilman Todenhöfer
- 49 views
- June 19, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Study EV-103 - Neoadjuvant Enfortumab Vedotin in Cisplatin-Ineligible MIBC Patients"
FEATURING
Nataliya Mar
- 124 views
- June 21, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MANCAN2 Trial - Self-Help Cognitive Behavioural Therapy for Hot Flashes and Night Sweats in Patients With Prostate Cancer Receiving ADT"
FEATURING
Simon Crabb
- 121 views
- June 17, 2024
ecancer
ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRPC Patients Treated with Lutetium-177-PSMA-617"
FEATURING
Karim Fizazi
- 69 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EMBARK Post Hoc Analysis of Sexual Activity PROs in Patients Who Were Sexually Active or Interested in Sex at Baseline"
FEATURING
Stephen Freedland
- 129 views
- June 5, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Harnessing the Immune System in RCC - Current and Novel IO Approaches"
FEATURING
David Braun
- 184 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EMBARK Study - Impact of Treatment Suspension on HRQoL in High-Risk BCR nmHSPC"
FEATURING
Stephen Freedland
- 145 views
- June 13, 2024
- 1
ecancer
ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel With Abiraterone vs. Abiraterone Alone in mCRPC Post Docetaxel"
FEATURING
Christos Kyriakopoulos
- 37 views
- June 21, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"
FEATURING
Eric Jonasch
- 184 views
- June 5, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Efficacy & Toxicity of 177Lu-PSMA-617 for mCRPC in a Real-World Setting - Results From the U.S. Expanded Access Program and Comparisons With Phase 3 VISION Data"
FEATURING
Vishnu Murthy
- 170 views
- June 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KEYNOTE-361 Trial - Quantitative ctDNA Assessment in Patients With Advanced UC Treated With Pembro or Platinum-Based Chemo"
FEATURING
Thomas Powles
- 177 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ARV-766, a PROTAC Androgen Receptor Degrader, in mCRPC - Initial Results of a Phase 1/2 Study"
FEATURING
Daniel Petrylak
- 80 views
- June 6, 2024
ecancer
ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab Govitecan +/- Pembro in MIBC"
FEATURING
Antonio Cigliola
- 37 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Oral and Injectable ADT in US Prostate Cancer Patients"
FEATURING
Jason Hafron
- 492 views
- June 13, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO in RCC"
FEATURING
Talal El Zarif
- 217 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Lenvatinib + Pembro vs. Sunitinib in aRCC - Patterns of Progression and Subsequent Therapy in the CLEAR Trial"
FEATURING
Viktor Grünwald
- 108 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer"
FEATURING
Yu-Wei Chen
- 123 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CORE-001 Study - Final Results of Cretostimogene Grenadenorepvec + Pembro in BCG-Unresponsive, High-Risk NMIBC With Carcinoma In Situ"
FEATURING
Roger Li
- 13 views
- June 13, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ABBV-706 Study - Targeted ADC for Advanced Solid Tumors"
FEATURING
Benjamin Garmezy
- 28 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CA-62 - A New Biomarker for the Detection of Early Stage RCC"
FEATURING
Evgueni Klinski
- 16 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "AURA Trial Survival Data - Avelumab as Neoadjuvant Therapy in MIUC"
FEATURING
Jeremy Blanc
- 159 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "HERCULES Trial - Pembro + Platinum-Based Chemo as 1L Treatment for Advanced Penile Cancer"
FEATURING
Fernando Maluf
- 83 views
- June 10, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KIM-1 Biomarker Analysis in IMmotion010 - Adjuvant Atezo vs. Placebo in RCC Patients at Increased Risk of Recurrence After Resection"
FEATURING
Laurence Albiges
- 57 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CheckMate 67T Trial - Safety & PROs of Subcutaneous vs. IV Nivo in Previously Treated Advanced or Metastatic ccRCC"
FEATURING
Maria Bourlon
- 83 views
- June 7, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "LITESPARK-013 Study Subgroup Analysis - Belzutifan in Advanced ccRCC"
FEATURING
Michael Atkins
- 88 views
- June 10, 2024